🕵️ Bright Minds Biosciences Inc. ($DRUG)
SEC insider & ownership activity, last 12 months · CIK 1827401 · every row links its SEC filing
Over the last 12 months insiders sold $9.8M with no open-market buying against it. Cormorant Asset Management, LP sold $9.8M in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $9.8M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 0 | – | 1 | $9.8M | Apr 28, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Biotech Innovation Master Fund Ltd | 14.0% | 13G | Aug 14, 2025 | filing ↗ | |
| Ian McDonald | 13.7% | 13D | Nov 4, 2024 | filing ↗ | |
| Janus Henderson Group PLC | 13.1% | 13G | May 15, 2026 | filing ↗ | |
| Bihua Chen | 10.9% | 13G | Feb 6, 2026 | filing ↗ | |
| Cormorant Asset Management, LP | 9.7% | 13G | Apr 30, 2026 | filing ↗ | |
| Chen Bihua | 9.7% | 13G | Apr 30, 2026 | filing ↗ | |
| Commodore Capital LP | 7.2% | 13G | Feb 14, 2025 | filing ↗ | |
| Adage Capital Management, L.P. | 5.6% | 13G | Nov 13, 2025 | filing ↗ | |
| Robert Atchinson | 5.6% | 13G | Nov 13, 2025 | filing ↗ | |
| Phillip Gross | 5.6% | 13G | Nov 13, 2025 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 5.2% | 13G | May 12, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 5.2% | 13G | May 12, 2026 | filing ↗ | |
| Vestal Point Capital, LP | 5.0% | 13G | May 15, 2026 | filing ↗ | |
| Ryan Wilder | 5.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.